MetaCap

ADMA Biologics (ADMA) News

NASDAQ: ADMAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

13.17-0.17 (-1.27%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ADMA news summary

We found 8 recent headlines mentioning ADMA Biologics (ADMA): 0 in the past week and 7 in the past 30 days, most often from Nasdaq, GlobeNewswire, Seeking Alpha. For price context, ADMA is down 1.27% at $13.17. The most recent story, "ADMA Surges 20.9% Post Q3 Earnings: Buy, Sell or Hold the Stock?", was published by Nasdaq on Nov 11, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest ADMA Biologics headlines

Stocks mentioned alongside ADMA

Compare ADMA